The US Refurbished Medical Equipment Market was valued at $1508 Million in 2024 and projected to reach to $2234.6 Million by 2029, representing a compound annual growth rate of 8.2%. The US refurbished medical equipment market is positioned for sustained expansion through 2029, driven by persistent healthcare budget constraints and the increasing credibility of refurbished solutions among US providers.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The US refurbished medical equipment market reached $1,508.0 million in 2024 and is projected to grow to $2,234.6 million by 2029, representing a robust 8.2% CAGR, outpacing the global average of 7.6%.
US hospitals face mounting budget constraints, making refurbished medical equipment an attractive alternative to new purchases. This cost-conscious approach enables healthcare facilities to maintain operational efficiency while reducing capital expenditures.
Growing emphasis on environmental responsibility across US healthcare systems is driving adoption of refurbished equipment, aligning with ESG goals and reducing medical waste while maintaining clinical standards.
Rising demand for diagnostic imaging and monitoring equipment in US healthcare facilities is accelerating the refurbished market, as providers seek certified, quality-assured alternatives at competitive price points.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | PET/SPECT SYSTEMS (Type) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 7.6% from 2024 to 2029 |
| Largest Segment | MEDICAL IMAGING EQUIPMENT (Product) |
| Market Size Base Year (Billions) | ~USD 16.92 (2024) |
| Revenue Forecast (Billions) | ~USD 24.41 (2029) |
| Segments Covered | Product, Type, End User |
3 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| GE HEALTHCARE | United States | Public Company | Imaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS), |
| SIEMENS HEALTHINEERS AG | Germany | Public Company | Imaging,Diagnostics,Varian (Oncology), |
| STRYKER | United States | Public Company | MedSurg and Neurotechnology,Orthopaedics Implants and Trauma/Extremities,Orthobiologics and Biosurgery, |
| SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. | China | Public Company | Patient Monitoring & Life Support (incl. ventilators, defibrillation, anesthesia),Ultrasound & Medical Imaging (incl. radiology, emergency ultrasound),In-Vitro Diagnostics (CLIA, chemistry, hematology), |
| DRÄGERWERK AG & CO. KGAA | Germany | Public Company | Acute care and perioperative equipment,Patient monitoring and informatics,Neonatal care and perinatal systems, |
| NIHON KOHDEN CORPORATION | Japan | Public Company | Patient monitors & clinical information systems,Physiological measuring equipment (EEG, ECG, EMG, polygraphs),Defibrillators, AEDs, ventilators, anesthesia, implants, |
| OLYMPUS CORPORATION | Japan | Public Company | Gastrointestinal Solutions (endoscopes, devices, services),Surgical Endoscopy Systems and Integrated OR Solutions,Advanced Energy Devices, |
GE Healthcare is a publicly traded U.S. company founded in 2022 with 54,000 employees, operating in the healthcare industry.
Siemens Healthineers AG is a German public company founded in 1896 with 72,369 employees, specializing in medical technology and diagnostics.
Stryker is a publicly traded U.S. medical device and healthcare company founded in 1941 with 56,000 employees.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a Chinese public company founded in 1991 with 21,288 employees, operating in the biomedical and medical device industry.
Drägerwerk AG & Co. KGaA is a German public company established in 1889 with 16,033 employees, operating in medical and safety technology.
Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees, specializing in medical electronic equipment and devices.
Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees, operating in precision optics and medical technology.
The US refurbished medical equipment market was valued at $1,508.0 million in 2024 and is expected to reach $2,234.6 million by 2029.
The US refurbished medical equipment market is projected to grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.
US healthcare providers are choosing refurbished equipment to reduce capital costs, improve budget efficiency, and access high-quality diagnostic and surgical devices that meet FDA standards.
The FDA regulates refurbished medical equipment in the US through strict certification and quality assurance processes to ensure that devices meet the same safety and performance standards as new equipment.
The most commonly refurbished medical equipment in the US includes diagnostic imaging devices (MRI, CT scanners), ultrasound systems, surgical equipment, and patient monitoring systems.
Major activities have been focused to estimate the market size of the Refurbished medical equipment sector at present. Extensive secondary research has been conducted to collate information regarding the refurbished medical equipment industry. Many different methodologies were used for estimating the overall market size, involving the top-down and bottom-up approaches. The next step involved primary research with industry experts along the value chain to validate these findings, assumptions, and market sizing. To do so, we employed market segmentation and data triangulation techniques to get an accurate market size across different market segments and subsegments of the Refurbished medical equipment market.
Secondary research sources of this study include directories and databases, such as D&B Hoovers and Factiva; white papers; Bloomberg Businessweek; annual reports; SEC filings; business filings; and investor presentations. The above sources have given information on leading companies and market segmentation that reflects the industry trend and technological perspectives of the Refurbished medical equipment market.
Major research activities entailed interviewing the supply side and the demand side, using both a quantitative and qualitative approach to data collection. Supply side information was obtained from key informants like CEOs, area sales managers, territory sales managers, regional sales managers, and other high-level officials from leading companies, while on the demand side, it mainly comprised physicians, researchers, department heads, and staff from diagnostic imaging centers, hospitals, and research institutions. This study was conducted for the purpose of ensuring that assumptions were validated through interaction with relevant stakeholders.
A breakdown of the primary respondents is provided below:
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.
To know about the assumptions considered for the study, download the pdf brochure
This research involves revenue sharing review of the leading players in the Refurbished medical equipment market. Primary and secondary research methods were adopted to determine the key players in the industry and to gain some level of understanding of their financial performance and market share. The primary research was more detailed interviews taken from the directors, CEOs and senior marketing executives, whereas the secondary research primarily relied upon the annual and financial reports issued by the major players in the industry. the revenue details of the leading solution providers were further used to differentiate between sources and services and a segment-based strategy was followed to determine the market value across the globe.
Identify the companies around the world who are leading Refurbished medical equipment industry and note down their respective annual revenues or specific product category/business division.
The revenue mapping of the key competitors, based on 2024, is in fact a major share of the market for this analysis, thus extrapolated to total global value for the Refurbished medical equipment market.

The Refurbished medical equipment market is segmented into various segments and subsegments based on the methodology adopted in this report. Data triangulation and the segmentation process are next undertaken to ensure the accuracy of data for all segments. Drivers and trends have been identified from both the supply and demand sides. The results obtained from both the top-down and bottom-up approaches have been utilized for deriving the results of the Refurbished medical equipment market analysis.
Refurbished medical equipment is used medical devices restored to their original operational condition and safety standards by the original manufacturer or a certified third-party provider. This typically includes cleaning, repairing, re-testing, and replacement of any worn-out components so that they meet regulatory and industry standards and are then deemed safe and effective. Refurbished equipment can add life to the original device, enabling the hospital and clinic facilities to save costs while using devices of worthy price and performance. Most of the time, warranties will show that there will be reliability of the equipment after restoration.
Full forecast, segment splits, and company analysis for all Refurbished Medical Equipment Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report